- Home
- AREB vs KAPA Comparison
AREB vs KAPA Comparison
Compare AREB & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- KAPA
- Stock Information
- Founded
- AREB 2014
- KAPA 2013
- Country
- AREB United States
- KAPA United States
- Employees
- AREB N/A
- KAPA N/A
- Industry
- AREB Plastic Products
- KAPA
- Sector
- AREB Industrials
- KAPA
- Exchange
- AREB Nasdaq
- KAPA NYSE
- Market Cap
- AREB 10.4M
- KAPA 10.8M
- IPO Year
- AREB N/A
- KAPA 2024
- Fundamental
- Price
- AREB $1.29
- KAPA $0.69
- Analyst Decision
- AREB
- KAPA Strong Buy
- Analyst Count
- AREB 0
- KAPA 3
- Target Price
- AREB N/A
- KAPA $8.33
- AVG Volume (30 Days)
- AREB 1.4M
- KAPA 2.2M
- Earning Date
- AREB 08-13-2025
- KAPA 08-23-2025
- Dividend Yield
- AREB N/A
- KAPA N/A
- EPS Growth
- AREB N/A
- KAPA N/A
- EPS
- AREB N/A
- KAPA N/A
- Revenue
- AREB $9,887,755.00
- KAPA N/A
- Revenue This Year
- AREB N/A
- KAPA N/A
- Revenue Next Year
- AREB N/A
- KAPA N/A
- P/E Ratio
- AREB N/A
- KAPA N/A
- Revenue Growth
- AREB N/A
- KAPA N/A
- 52 Week Low
- AREB $1.10
- KAPA $0.40
- 52 Week High
- AREB $231.75
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- AREB 34.22
- KAPA N/A
- Support Level
- AREB $1.35
- KAPA N/A
- Resistance Level
- AREB $1.48
- KAPA N/A
- Average True Range (ATR)
- AREB 0.13
- KAPA 0.00
- MACD
- AREB 0.05
- KAPA 0.00
- Stochastic Oscillator
- AREB 0.00
- KAPA 0.00
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.